Log In
Print
BCIQ
Print
Print this Print this
 

Prochymal, remestemcel-L

  Manage Alerts
Collapse Summary General Information
Company Mesoblast Ltd.
DescriptionIV formulation of mesenchymal stem cells (MSCs)
Molecular Target Not applicable
Mechanism of ActionCell therapy; Immune modulation
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$100.0M

$20.0M

$50.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today